Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed/Refractory Multiple Myeloma(MM)

Clinical trial condition

Relapsed/Refractory Multiple Myeloma(MM)

Explore clinical trials studying Relapsed/Refractory Multiple Myeloma(MM). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Relapsed/Refractory Multiple Myeloma(MM) trial results

Recruiting

Allogeneic UCB-derived, Dual-targeting BCMA/CD19 CAR-T for Relapsed/Refractory Multiple Myeloma

NCT07139509

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Xi'an No.3 Hospital Xi’an, Shanxi, China

View Trial Details